Guide
GLP-1 Prior Authorization: What Plans Ask For and How to Prepare
Prior authorization is a documentation exercise, not a clinical argument. Plans publish criteria; approval turns on whether your record contains the specific elements tho
Prior authorization is a documentation exercise, not a clinical argument. Plans publish criteria; approval turns on whether your record contains the specific elements those criteria name, in the format the reviewer expects. Getting the written criteria before submission is the single highest-yield step.
What prior authorization actually is
A requirement that your plan approve a drug before it will pay. The plan publishes criteria, your prescriber submits documentation, and a reviewer decides whether the documentation matches.
That framing matters because it tells you where to put effort. Most denials are not the plan disagreeing that you need the drug. They are the submission failing to contain something the criteria require, in a form the reviewer could find.
Get the criteria first
Ask your plan for the prior-authorization criteria for the specific drug, in writing. Many publish them; all will provide them on request. This single step changes the exercise from guessing to matching.
Read them literally. If the criteria name a BMI threshold with a comorbidity, the submission needs both documented, with dates. If they require a documented trial of lifestyle intervention over a stated period, a note saying "patient has tried diet and exercise" will not satisfy it.
What criteria commonly require
These vary by plan and this is not a checklist to submit — it is what to expect so you can ask your prescriber whether your record covers it.
- BMI thresholds, often with an alternative lower threshold where a weight-related comorbidity is present.
- Documented comorbidity, coded, not described in narrative.
- Prior lifestyle intervention, frequently with a duration requirement.
- Step therapy — a documented trial of a preferred alternative, with the outcome recorded.
- Baseline measurements with dates in the record.
- Exclusion screening, notably personal or family history of medullary thyroid carcinoma or MEN 2, which are contraindications on the label.
Where submissions fail
Missing dates. A criterion requiring six months of documented intervention needs entries showing that period, not a summary written today.
Narrative instead of codes. Reviewers work from structured data. A comorbidity described in free text may not register.
The wrong indication. If your plan covers a molecule for diabetes and not for weight management, submitting under the weight-management indication produces a denial that is procedurally correct.
Step therapy unaddressed. If a preferred alternative exists, the submission needs to say what happened when it was tried, or why it is contraindicated.
What you can usefully do
Bring your prescriber the written criteria. Ask directly whether your record contains each element and, where it does not, what would be needed. Ask who at the practice handles prior authorizations — in many, it is a specific administrator rather than the clinician, and reaching them saves weeks.
Keep your own copy of what was submitted and when. If it is denied, you appeal against a specific document, and you will want to know what the reviewer actually saw.
Timelines
Standard determinations typically run days to a couple of weeks; expedited review exists where a delay would jeopardise health, and your prescriber requests it. If a decision is overdue, call and cite the date of submission. Plans have deadlines and they are enforceable.
If it is denied
A first-level denial is routinely overturned on appeal, particularly where the denial was documentary rather than clinical. See the appeal guide, and request the denial reason in writing before doing anything else.
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Questions readers actually ask
How long does GLP-1 prior authorization take?
Standard determinations typically take days to a couple of weeks. Expedited review exists where delay would jeopardise health and is requested by the prescriber.
Why was my prior authorization denied?
Most denials are documentary rather than clinical — a criterion the submission did not address, missing dates, an unaddressed step-therapy requirement, or the wrong indication.
Can I see the criteria my plan uses?
Yes. Ask your plan for the prior-authorization criteria for the specific drug in writing. Many publish them and all will provide them on request.
Related on this site
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Ro Body vs Hims & HersComparisons
- Hims & Hers vs Henry MedsComparisons
- Brand-Name vs Compounded TirzepatidePillar / Money
- NexLife vs Hims & HersComparisons
- Mounjaro vs ZepboundPillar / Money
- Hims & Hers Tirzepatide ReviewProviders
- Compounded vs Brand Tirzepatide: Legal and Evidence DifferencesJournal
Related coverage
- GLP-1 insurance coverage
- Appealing a denial
- When your plan drops coverage
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- Editorial Standards
- What Happens After You Stop Tirzepatide?
- BPC-157: The Evidence, the Regulatory Position, and Why the Two Diverge
- Tirzepatide and Type 2 Diabetes Prevention
GLP-1 Tirzepatide Reviews. “GLP-1 Prior Authorization: What Plans Ask For and How to Prepare.” S.J Partners LLC, 2026-07-24. https://glptirzepatidereviews.com/insurance/prior-authorization/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.